Nasdaq (NDAQ) Stock

Adicet Bio, Inc., a biotechnology company focused on creating therapies for autoimmune diseases and cancer, announced on January 31, 2025, that it offered inducement awards. The company hired two new employees in January 2025 and provided them with non-qualified stock options to buy a total of 28,600 shares of its common stock at an exercise price of $0.89 per share.

CENTENNIAL, CO / ACCESS Newswire / January 31, 2025 / NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:NB) has completed its previously announced underwritten offering. This offering included 2,577,320 common shares, 2,577,320 Series A warrants for purchasing common shares, and 1,288,660 Series B warrants for additional common shares.

DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fusion Fuel Green PLC (Nasdaq: HTOO) has announced that Nasdaq's Listing Qualifications Department has approved its request to move its Class A Ordinary Shares and publicly-traded warrants to The Nasdaq Capital Market from The Nasdaq Global Market. This change will be effective starting February 3, 2025. Fusion Fuel is known for its energy engineering, advisory, and supply solutions.

The total worth of all investment products that follow the NDX® ecosystem around the world is more than $500 billion.

SOUTH SAN FRANCISCO, Calif., Jan. 31, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a company focused on precision medicine in oncology, announced that on January 30, 2025, its Compensation Committee approved non-qualified stock options for a total of 62,800 shares of common stock. These options were granted to two new employees.

HANOVER, Md, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) is a clinical-stage pharmaceutical company that is working on developing new chemotherapeutic drugs that are safer and more effective. The company has successfully completed its public offering, which included participation from its CEO, some board members, and existing institutional investors, as well as a healthcare-focused institutional investor. This offering involved 8,050,672 shares of common stock and various warrants, with a purchase price of $0.615 for institutional investors and $0.7975 for the CEO and board members, and the closing took place on January 29, 2025.

Apple reported higher earnings but fell short on iPhone sales, causing its shares to drop by 1.6% in after-hours trading. Revenue from China decreased by 11%. What will happen next for AAPL?

CHERRY HILL, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (Nasdaq: RGF) ("Real Good Foods" or the "Company"), a top company in health and wellness frozen and refrigerated foods, has announced that it plans to voluntarily remove its common stock from the Nasdaq Stock Market, LLC ("Nasdaq") and will also deregister with the Securities and Exchange Commission ("SEC"). This decision was made by the Company's Board of Directors on January 27, 2025.

On January 30, 2025, 60 Degrees Pharmaceuticals, Inc. announced that it has completed its registered direct offering, selling 1,021,549 shares of common stock at a price of $1.021 each. The company also issued unregistered short-term warrants in a private placement, allowing the purchase of an additional 2,043,098 shares of common stock. This move is part of the company's efforts to develop new medicines for infectious diseases.